UGI Flashcards
1
Q
Options for second line in metastatic gastric cancer
A
Paclitaxel
Docetaxel
Irinotecan
Ramucirumab +- paclitaxel (anti VEGFR2 monoclonal ab) not in UK but phase 3 evidence it improves survival compared to BSC
Basma Medical Oncology > UGI > Flashcards
Options for second line in metastatic gastric cancer
Paclitaxel
Docetaxel
Irinotecan
Ramucirumab +- paclitaxel (anti VEGFR2 monoclonal ab) not in UK but phase 3 evidence it improves survival compared to BSC
Basma Medical Oncology (26 decks)